Medline Inc. MDLN
6 trading plans running, 3 Form 144 notices for $6.9M
10-Q, 10-K and Form 144What MDLN's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Mar 10, 2026 to Jul 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Stephen L. Miller Former Chief Operating Officer |
Ended 10b5-1 plan | Aug 13, 2026 | 10-Q Nov 4, 2026 | ||
What the company wroteThe trading arrangement listed below was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. Name Title Date of Adoption or Termination Duration of Trading Arrangement Number of Shares to be Sold Pursuant to the Trading Arrangement Stephen L. Miller Former Chief Operating Officer Terminated his previously disclosed plan on August 13, 2026 The terminated plan was scheduled to expire December 31, 2026 The terminated plan covered up to 100% of the shares of Class A common stock issued upon the vesting and exchange of 808,451 Incentive Units | |||||
| William J. Abrams Executive Vice President, Supply Chain Solutions |
Adopted 10b5-1 plan | May 26, 2026 | 10-Q Aug 5, 2026 | ||
What the company wroteThe trading arrangement listed below is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Name Title Date of Adoption or Termination Duration of Trading Arrangement Number of Shares to be Sold Pursuant to the Trading Arrangement* William J. Abrams Executive Vice President, Supply Chain Solutions Adopted on May 26, 2026 November 12, 2026 – March 31, 2027 Up to 1,139,433 shares of Class A common stock * Represents the maximum number of shares that may be sold pursuant to the trading arrangement. The actual number of shares sold will depend upon the satisfaction of certain conditions as set forth in the written plan. | |||||
| Amanda H. Laabs Chief Product Officer |
Adopted 10b5-1 plan | Mar 12, 2026 | 10-Q May 6, 2026 | ||
| James M. Boyle Chief Executive Officer and Director |
Adopted 10b5-1 plan | Mar 12, 2026 | 10-Q May 6, 2026 | ||
| Alex M. Liberman Chief Legal Officer |
Adopted 10b5-1 plan | Mar 11, 2026 | 10-Q May 6, 2026 | ||
| Douglas P. Golwas Chief Commercial Officer |
Adopted 10b5-1 plan | Mar 11, 2026 | 10-Q May 6, 2026 | ||
| Stephen L. Miller Chief Operating Officer |
Adopted 10b5-1 plan | Mar 11, 2026 | 10-Q May 6, 2026 | ||
| Michael B. Drazin Chief Financial Officer |
Adopted 10b5-1 plan | Mar 10, 2026 | 10-Q May 6, 2026 | ||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 4 filings checked since Feb 25, 2026.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 13, 2026 | Stephen Miller Officer |
39,819 | $1.6M |
| Nov 13, 2026 | Stephen Miller Officer |
39,819 | $1.6M |
| Jun 16, 2026 | Douglas Golwas Officer |
100,000 | $3.6M |
From the Form 144 XML filed with the SEC, since Jun 16, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDLN/export.csv") into a cell.